Cite
HARVARD Citation
Cheng, L. et al. (2021). Sintilimab plus IBI305 for hepatocellular carcinoma. Lancet oncology. 22 (9), pp. e387-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cheng, L. et al. (2021). Sintilimab plus IBI305 for hepatocellular carcinoma. Lancet oncology. 22 (9), pp. e387-. [Online].